Research

 
Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays
May 19, 2023
Thermo Fisher Scientific Gets FDA Clearance for Preeclampsia Risk Assessment Assays

A new diagnostic test for preeclampsia has received approval from the US Food and Drug Administration for use in hospital settings.

Could scheduled childbirth reduce cases of at-term preeclampsia?
April 27, 2023
Could scheduled childbirth reduce cases of at-term preeclampsia?

A new research study published out of the UK in April 2023 in Hypertension found that more than half of all preeclampsia cases which occur during weeks 37-42 of pregnancy (“at-term”) may be prevented with timed birth. Screening for preec...

Does pravastatin during pregnancy have long-term effects on children?
April 26, 2023
Does pravastatin during pregnancy have long-term effects on children?

Based on limited data, pravastatin use during pregnancy does not appear to have any long-term adverse effects on children. his information will be useful for gaining approval for larger studies to see if pravastatin is actually useful in preventing...

Messenger RNA through ionizable lipid nanoparticles to improve placental blood vessel creation
April 26, 2023
Messenger RNA through ionizable lipid nanoparticles to improve placental blood vessel creation

In this paper, researchers describe how they developed an ionized lipid nanoparticle that is taken into mouse placental cells to increase VEGF.

More sleep, veggies, and movement to reduce risk for a hypertensive disorder of pregnancy
April 26, 2023
More sleep, veggies, and movement to reduce risk for a hypertensive disorder of pregnancy

Identifying the healthful behaviors that lower the risk for a hypertensive disorder of pregnancy can help develop recommendations and prevention programs to support lowering pregnant women’s risk for developing a hypertensive disorder of pregnancy.

One-in-a-trillion – understanding single-cell sequencing to understand preeclampsia
April 26, 2023
One-in-a-trillion – understanding single-cell sequencing to understand preeclampsia

Genetic research over the past 10 years has shown a difference in gene expression in single-cells from placentas of pregnancies with preeclampsia compared to normotensive placentas.

Combining lab results and clinical characteristics to predict HELLP syndrome
April 26, 2023
Combining lab results and clinical characteristics to predict HELLP syndrome

Researchers asked if microRNAs that are linked to cardiovascular disease in non-pregnant people could help predict HELLP syndrome.

What do we know? Creating an effective understanding of nutrition and preeclampsia
March 23, 2023
What do we know? Creating an effective understanding of nutrition and preeclampsia

Researchers have found several maternal nutritional and dietary factors that may increase or decrease the risk of developing preeclampsia, though the association between the two is complex.

What are the risk factors for preeclampsia? An updated research perspective
February 28, 2023
What are the risk factors for preeclampsia? An updated research perspective

What you’ll learn in this article: Many risk factors contribute to an individual’s chance of getting preeclampsia. These risk factors may be genetic, physical, environmental, and even social. Don’t blame yourself for developing...

Preeclampsia Foundation Canada announces 2023 Vision Grant Research Funding for Preeclampsia at 2023 SMFM Pregnancy Meeting
February 08, 2023
Preeclampsia Foundation Canada announces 2023 Vision Grant Research Funding for Preeclampsia at 2023 SMFM Pregnancy Meeting

Preeclampsia Foundation Canada announced today at the Society for Maternal-Fetal Medicine’s (SMFM) 43rd Annual Meeting – The Pregnancy Meeting™ – that applications are now being accepted for its 2023 Vision Grant program.

New Preeclampsia Research Funded to Investigate Genetic Targets to Develop Potential Therapeutics
February 08, 2023
New Preeclampsia Research Funded to Investigate Genetic Targets to Develop Potential Therapeutics

The study is designed to potentially accelerate discovery of therapies for preeclampsia by designing placental cell lines that express variants of the APOL1 gene for drug screening.

Peter J. Pappas Grant Recipients
January 02, 2023
Peter J. Pappas Grant Recipients

Peter Joseph Pappas preeclampsia research grant recipients' study titles and reports.

LOAD MORE